What is the price target for NMTC stock?
8 analysts have analysed NMTC and the average price target is 2.07 USD. This implies a price increase of 160.88% is expected in the next year compared to the current price of 0.795.
NEUROONE MEDICAL TECHNOLOGIE (NMTC) Forecast, Price Target & Analyst Ratings
NASDAQ:NMTC • US64130M2098
Current stock price
0.795 USD
-0.01 (-0.87%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEUROONE MEDICAL TECHNOLOGIE (NMTC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 11, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 2.628M
Price Target Details & History
Consensus Price Target and Range
Mean target
$2.07
Upside
+ 160.88%
From current price of $0.80 to mean target of $2.07, Based on 8 analyst forecasts
Low
$1.52
Median
$1.63
High
$3.15
Price Target Revisions
1 Month
-11.60%
3 Months
-8.62%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for NMTC. The average price target is 2.07 USD. This implies a price increase of 160.88% is expected in the next year compared to the current price of 0.795.
The average price target has been revised downward by 8.62% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.00%
NMTC was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NMTC.
In the previous month the buy percentage consensus was at a similar level.
NMTC was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | Jones Trading | Initiate | Buy |
| 2025-09-09 | Maxim Group | Initiate | Buy |
| 2025-05-05 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-15 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2021-12-03 | Alliance Global Partners | Initiate | Buy |
| 2021-11-15 | Craig-Hallum | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.04
- Revenue Estimate
- 2.628M
- Revenue Q2Q
- 89.06%
- EPS Q2Q
- 46.57%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
5.67%
Revenue (3 Months)
4.20%
EPS (1 Month)
18.51%
EPS (3 Months)
26.66%
Next Earnings Summary
NMTC is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.04 USD and the consensus revenue estimate is 2.63M USD.
The next earnings revenue estimate has been revised upward by 4.2% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.448M 62.66% | 3.453M 0.13% | 12.098M 250.35% | 11.69M -3.37% | 15.419M 31.90% | 23.148M 50.13% | |
| EBITDA YoY % growth | -11.756M -18.63% | -11.64M 0.98% | -3.965M 65.94% | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.955M -19.20% | -11.887M 0.57% | -4.227M 64.44% | -7.5M -77.45% | -5.64M 24.80% | -1.362M 75.85% | |
| Operating Margin | -346.69% | -344.26% | -34.94% | -64.16% | -36.58% | -5.88% | |
| EPS YoY % growth | -0.65 -3.17% | N/A 34.09% | -0.08 81.33% | -0.14 -78.50% | -0.10 28.57% | -0.03 70.00% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 46.57% | -0.03 -2.00% | -0.03 31.99% | -0.02 32.00% | -0.02 45.46% | -0.02 50.00% | -0.01 62.50% | -0.01 50.00% | -0.02 | -0.01 33.33% | 0.00 100.00% |
| Revenue Q2Q % growth | 2.628M 89.06% | 2.861M 68.69% | 3.251M 18.61% | 3.893M 34.58% | 3.784M 43.99% | 4.193M 46.56% | 4.828M 48.51% | 5.773M 48.29% | 5.11M 35.04% | 5.63M 34.27% | 6.712M 39.02% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.058M 23.21% | -1.923M -1.95% | -1.776M -29.54% | -1.38M 19.20% | -1.485M 27.86% | -1.211M 37.03% | -837.93K 52.82% | -591.6K 57.12% | -1.061M 28.55% | -622.2K 48.63% | 20.4K 102.43% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
17.39%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
36.63%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
NEUROONE MEDICAL TECHNOLOGIE / NMTC Forecast FAQ
Can you provide the upcoming earnings date for NEUROONE MEDICAL TECHNOLOGIE?
NEUROONE MEDICAL TECHNOLOGIE (NMTC) will report earnings on 2026-05-11.
What are the consensus estimates for NEUROONE MEDICAL TECHNOLOGIE (NMTC) next earnings?
The consensus EPS estimate for the next earnings of NEUROONE MEDICAL TECHNOLOGIE (NMTC) is -0.04 USD and the consensus revenue estimate is 2.63M USD.
Can you provide the analyst count for NEUROONE MEDICAL TECHNOLOGIE stock?
The number of analysts covering NEUROONE MEDICAL TECHNOLOGIE (NMTC) is 8.